Transmethylation reactions and autoradiographic distribution of vitamin B12: Effects of clioquinol treatment in mice

Japanese Journal of Pharmacology

Volumn 78, Issue 1, 1998, Pages 55-61

  Yassin, Mohammed S ^a   Ekblom, Jonas ^a   Löfberg, Charlotta ^a   Oreland, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Clioquinol; L methionine S adenosyltransferase; S adenosylmethionine; Subacute myelo optic neuropathy (SMON); Vitamin B12

Indexed keywords

CLIOQUINOL; COBALT; COBALT 57; CYANOCOBALAMIN; METHIONINE ADENOSYLTRANSFERASE; QUINOLINOL DERIVATIVE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN; BRAIN STEM; CEREBELLUM; CHELATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG UPTAKE; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; MALE; METHYLATION; MOUSE; NONHUMAN; PARTITION COEFFICIENT; SKIN; SUBACUTE MYELOOPTIC NEUROPATHY;

EID: 0031693030     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.55     Document Type: Article

References (23)

1. Kono R: Subacute myelo-optic-neuropathy, a new neurological disease prevailing in Japan. Jpn J Med Sci Biol 24, 195-216 (1971)
2. Kono R: Introductory review of subacute myelo-optic-neuropathy (SMON) and its studies done by the SMON research Commission. Jpn J Med Sci Biol 28, Suppl, 1-21 (1975)
3. Baumagartner G, Gawel MJ, Kaeser HE, Pallis CA, Cliffordrose F, Schaumburg HH, Thomas PK and Wadia H: Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. J Neurol Neurosurg Psychiatry 42, 1073-1083 (1979)
4. Tjälve H and Stahl K: Effect of 5-chloro-7-iodo-8-hydroxyquinoline (Clioquinol) on the uptake and distribution of nickel, zinc and mercury in mice. Acta Pharmacol Toxicol 55, 65-72 (1984)
5. Ohtsuka K, Ohishi N, Eguchi G and Yagi K: Degeneration of retinal neuroblasts by chinform-ferric chelate. Experientia 38, 120-122 (1982)
6. 12. Levels of cereberospinal fluid in patients with a variety of neurological disorders. J Nutr Sci Vitaminol 23, 299-304 (1977)
7. Rollo IM: Drugs used in the chemotherapy of amebiasis. In The Pharmacological Basis of Therapeutics, Edited by Goodman S and Gilman A, pp 1069-1080, Macmillan Publication Co, Inc. New York (1975)
8. Cantoni GL: S-Adenosylmethionine; A new intermediate formed enzymatically from L-methionine and adenosinetriphosphate. J Biol Chem 204, 403-416 (1953)
9. Cantoni GL and Durell J: Activation of methionine for transmethylation, II. The methionine activating enzyme: Studies on the mechanism of the reaction. J Biol Chem 225, 1033-1048 (1957)
10. Surtees R and Hyland K: Cerebrospinal fluid concentrations of S-adenosylmethionine, methionine, and 5-methyltetrahydrofolate in a reference population: Cerebrospinal fluid S-adenosylmethionine declines with age in humans. Biochem Med Metabol Biol 44, 192-199 (1990)
11. Bottiglieri T, Godfrey P, Flynn T, Carney MWP, Toone BK and Reynolds EH: Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 53, 1096-1098 (1990)
12. Lever EG, Elwes RDC, Williams A and Reynolds EH: Subacute combined degeneration of the cord due to folate deficiency response to methyl folate treatment. J Neurol Neurosurg Psychiatry 49, 1203-1207 (1986)
13. Bottiglieri T and Hyland K: S-Adenosylmethionine levels in psychiatric and neurological disorders: a review. Acta Neurol Scand 89, Suppl 154, 19-26 (1994)
14. Benson R, Crowell B, Hill B, Doonquah K and Charlton C: The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance. Neurochem Res 18, 325-330 (1993)
15. Gomes-Trolin C, Ekblom J and Oreland L: Regulation of methionine adenosyltransferase catalytic activity and messenger RNA in SH-SY5Y human neuroblastoma cells. Biochem Pharmacol 55, 567-571 (1998)
16. Ullberg S: Autoradiographic studies on the distribution of lebelled drugs in the body. Second UN Int Conf Peaceful Uses of Atomic Energy 24, 248 (1958)
17. Prince JA, Yassin MS and Oreland L: Neuroleptic-induced mitochondrial enzyme alterations in the rat brain. J Pharmacol Exp Ther 1, 261-267 (1997)
18. Markwell MAK, Haas SM, Bieber LL and Tolbert NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87, 206-210 (1978)
19. Oden KL and Clark S: S-Adenosyl-L-methionine synthetase from human erythrocytes: role in the regulation of cellular S-adenosylmethionine levels. Biochemistry 22, 2978-2986 (1983)
20. 12. Acta Radiol Suppl 284, 1-79 (1968)
21. Ogata M, Watanabe S, Tateishi J, Kuroda S, Kira S, Hasegawa T and Otsuki S: Organ disribution and metabolism of radioactive iodochlorohydroxyquinoline (clioquinol, chinoform) in animals. Folia Psychiarty Neurol Jpn 28, 243-257 (1974)
22. Watanabe S, Tateishi J, Kuroda S, Otsuki S and Ogata M: Distribution of clioquinol in rats with hepatic dysfunction. Lancet 2, 681-682 (1973)
23. Bush AI, Pettingell WH, Multhaup G, Paradis MD, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL and Tanzi RE: Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265, 1464-1467 (1994)